Trial Profile
Afuresertib for Langerhans Cell Histiocytosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2014
Price :
$35
*
At a glance
- Drugs Afuresertib (Primary)
- Indications Langerhans cell histiocytosis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 21 Oct 2014 New trial record